|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 27/62 | |
| G01N 33/15 | |||
| G01N 33/50 | |||
| G01N 33/53 | |||
| C12Q 1/02 |
| (11) | Patento numeris | 3213062 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15856119.1 |
| Europos patento paraiškos padavimo data | 2015-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/057963 |
| Data | 2015-10-29 |
| (87) | Numeris | WO 2016/069847 |
| Data | 2016-05-06 |
| (30) | Numeris | Data | Šalis |
| 201462073320 P | 2014-10-31 | US |
| (72) |
WOOLF, Clifford J., US
LATINI, Alexandra S., US
ANDREWS, Nick A., US
LATREMOLIERE, Alban, US
COSTIGAN, Michael, US
|
| (73) |
Children`s Medical Center Corporation,
55 Shattuck Street, Boston, MA 02115,
US
|
| (54) | METHODS AND ASSAYS RELATING TO SEPIAPTERIN REDUCTASE INHIBITION |
| METHODS AND ASSAYS RELATING TO SEPIAPTERIN REDUCTASE INHIBITION |